The past year hasn’t been kind to the stocks featured in this article. Each has tumbled to its lowest point in 12 months, leaving investors to decide whether they’re witnessing fire sales or falling knives.
At StockStory, we dig beneath the surface of price movements to uncover whether a company’s fundamentals justify its current valuation or suggest hidden potential. Keeping that in mind, here are three stocks facing legitimate challenges and some alternatives worth exploring instead.
Inspired (INSE)
One-Month Return: -18.8%
Specializing in digital casino gaming, Inspired (NASDAQ: INSE) is a provider of gaming hardware, virtual sports platforms, and server-based gaming systems.
Why Do We Steer Clear of INSE?
- 7.5% annual revenue growth over the last five years was slower than its consumer discretionary peers
- Lacking free cash flow generation means it has few chances to reinvest for growth, repurchase shares, or distribute capital
- Waning returns on capital from an already weak starting point displays the inefficacy of management’s past and current investment decisions
Inspired is trading at $5.58 per share, or 25x forward P/E. If you’re considering INSE for your portfolio, see our FREE research report to learn more.
Watsco (WSO)
One-Month Return: -6.4%
Originally a manufacturing company, Watsco (NYSE: WSO) today only distributes air conditioning, heating, and refrigeration equipment, as well as related parts and supplies.
Why Do We Think WSO Will Underperform?
- Products and services are facing significant end-market challenges during this cycle as sales have declined by 1% annually over the last two years
- Earnings per share decreased by more than its revenue over the last two years, partly because it diluted shareholders
- Shrinking returns on capital suggest that increasing competition is eating into the company’s profitability
At $313.75 per share, Watsco trades at 24.9x forward P/E. Read our free research report to see why you should think twice about including WSO in your portfolio.
LeMaitre (LMAT)
One-Month Return: -23.9%
Founded in 1983 and named after a pioneering vascular surgeon, LeMaitre Vascular (NASDAQGM:LMAT) develops and manufactures specialized medical devices used by vascular surgeons to treat peripheral vascular disease and other circulatory conditions.
Why Are We Hesitant About LMAT?
- Subscale operations are evident in its revenue base of $262.4 million, meaning it has fewer distribution channels than its larger rivals
LeMaitre’s stock price of $80.50 implies a valuation ratio of 26.7x forward P/E. To fully understand why you should be careful with LMAT, check out our full research report (it’s free).
Stocks We Like More
ALSO WORTH WATCHING: Top 5 Momentum Stocks. The best time to own a great stock is when the market is finally noticing it. These aren’t just high-quality businesses. Something is happening with them right now. Elite fundamentals meet near-term momentum — both boxes checked at the same time.
Find out which stocks our AI platform is flagging this week. See this week’s Strong Momentum stocks — FREE. Get Our Strong Momentum Stocks for Free HERE.
Stocks that made our list in 2020 include now familiar names such as Nvidia (+1,460% between June 2020 and June 2025) as well as under-the-radar businesses like the once-micro-cap company Tecnoglass (+1,552% between June 2020 and June 2025). Find your next big winner with StockStory today.
